iShares Neuroscience and Healthcare ETF IBRN
Set alert
32.84 USD -0.45 -1.35%
As of Oct 30, 3:12 PM ET
32.75 Day range 32.84
27.97 52-week range 40.67
- YTD
- +1.60%
- 1 year
- +9.17%
- Open
- 32.75
- Prev close
- 33.29
- Mkt cap
- 5.30M
- Vol
- 1.77K
- Avg vol
- 2.35K
- EPS
- 1.39
- P/E
- 23.63
- Div yield
- 0.00%
More statistics
- Low
- 32.75
- High
- 32.84
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 26.81
- 200-d avg
- 25.11
3M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| RSI: Oversold | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 26.81
- 200-day average
- 25.11
About iShares Neuroscience and Healthcare ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.
News
- FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
- PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity'
- Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures
- These 10 ETFs Were Last Week's Top Performers: Oct 3, 2022
- 4 Best ETF Areas of Last Week That Are Up At Least 5%
- Why Now Could Be The Time To Consider Neuroscience Investments
Your note
Sign in to keep a note on IBRN — it syncs with the Stock Master app.